Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | RBN-2397 |
Trade Name | |
Synonyms | RBN2397|Atamparib |
Drug Descriptions |
RBN-2397 is a small molecule inhibitor that targets PARP7, potentially inducing type I interferon signaling, which may lead to an immune response and tumor regression (PMID: 34375612). |
DrugClasses | |
CAS Registry Number | 2381037-82-5 |
NCIT ID | C170764 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + RBN-2397 | Pembrolizumab RBN-2397 | 0 | 1 |
RBN-2397 | RBN-2397 | 0 | 1 |